Human Topoisomerase I (hTop1p) is a ubiquitous enzyme that relaxes supercoiled DNA through a conserved mechanism involving transient breakage, rotation, and binding. Htop1p is the molecular target of the chemotherapeutic drug camptothecin (CPT). It causes the hTop1p-DNA complex to slow down the binding process and clash with the replicative machinery during the S phase of the cell cycle, forcing cells to activate the apoptotic response. This gives hTop1p a central role in cancer therapy. Recently, two artesunic acid derivatives (compounds c6 and c7)have been proposed as promising inhibitors of hTop1p with possible antitumor activity. Classical molecular dynamics simulation was performed to assess the ability of the two compounds to maintain a stable binding pose over time. The three folders contains files concerning the input and output data from the docking process of the compuonds candidates. docking_structures_pdqt: obtained using autodock tools 4.2.6. best_poses_output_docking: obtained using autodock vina 1.2.0. docking_configuration_file: configuration files that define the receptor, ligand input, the center and size of the search space. Authors: [Francesco Madeddu, Jessica Di Martino, Michele Pieroni, Davide Del Buono, Paolo Bottoni, Lorenzo Botta, Tiziana Castrignanò, and Raffaele Saladino]